Αποτελέσματα Αναζήτησης
The Kintara Therapeutics Inc (KTRA) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $73.32, representing a + increase from the current price of $0.00. The highest analyst price target is $117.20, and the lowest is $29.44.
Find the latest Kintara Therapeutics, Inc. KTRA analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.
Kintara Therapeutics Inc Stock forecast & analyst price target predictions, earnings, revenue ,EPS predictions, upgrades and downgrades.
18 Οκτ 2024 · Stock analysis for Kintara Therapeutics Inc (KTRA:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
The average one-year price target for Kintara Therapeutics, Inc. is $14.28. The forecasts range from a low of $14.14 to a high of $14.70. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings.
Real time Kintara Therapeutics (KTRA) stock price quote, stock graph, news & analysis.
6 ημέρες πριν · TuHura Biosciences, Inc. and Kintara Therapeutics, Inc. Announces Positive Results from Phase 1b Trial of IFx-2.0. Jun. 03. CI. Kintara Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024.
